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Abstract An extract of skin taken from specimens of the
freeze-tolerant wood frog, Rana sylvatica, that were collected
from cold ( 67‡C) ponds and maintained at 5‡C lacked
detectable antimicrobial activity. In contrast, an extract of skin
taken from specimens maintained at 30‡C for 3 weeks under
laboratory conditions contained a high concentration (approxi-
mately 4 nmol/g) of a single antimicrobial peptide of the brevinin-
1 family (FLPVVAGLAAKVLPSIICAVTKKC). The peptide
inhibited growth of Escherichia coli (minimum inhibitory
concentration 45 WM) and Staphylococcus aureus (minimum
inhibitory concentration 7 WM). The data suggest that synthesis
of the peptide is induced when the animal is in an environment
that promotes the growth of microorganisms consistent with a
role in the animal’s defense strategy. ß 2000 Federation of
European Biochemical Societies. Published by Elsevier Science
B.V. All rights reserved.
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1. Introduction
The wood frog Rana sylvatica is the most extensively
studied of a small group of terrestrially hibernating amphib-
ians that can withstand the freezing of extracellular body £u-
ids during winter hibernation [1]. The onset of freezing is
accompanied by physiological changes that include accumu-
lation of high concentrations of glucose, derived primarily
from hepatic glycogen stores, that acts as a cryoprotectant,
cardioacceleration to distribute the glucose throughout the
body, ischemia due to the plasma freezing, and reduction of
cell volume in all organs due to water loss into extracellular
ice masses [1^3]. Freezing is also associated with the up-reg-
ulation of expression of several genes, including those encod-
ing ice-nucleation proteins [4], the K- and Q-subunits of ¢brin-
ogen [5], mitochondrial ADP/ATP translocase [6], a novel 10
kDa protein (Fr10) containing a nuclear exporting sequence
[7] and several, as yet uncharacterized, proteins in liver, skel-
etal muscle, heart and brain [8]. The skin is clearly the ¢rst
organ in the animal to experience changes in the environment
but the e¡ects of freezing and/or thawing on the regulation of
gene expression in R. sylvatica skin have not been reported.
The skins of all frogs of the genus Rana yet studied (re-
viewed in [9^11]) contain granular glands that synthesize a
wide range of antimicrobial peptides that are released into
skin secretions as a result of contraction of myocytes sur-
rounding the glands [9]. These peptides have been recently
classi¢ed into eight families on the basis of amino acid se-
quence similarities and comprise the brevinin-1, brevinin-2,
esculentin-1, esculentin-2, ranalexin, ranatuerin-1, ranatuer-
in-2 and temporin families [10]. It has been proposed that
these peptides represent an important component of the ani-
mal’s defense strategy protecting it against the range of patho-
genic microorganisms that might be encountered in nature
[12] but ¢rm evidence to support this hypothesis is lacking.
The present study demonstrates for the ¢rst time induction of
the synthesis of an antimicrobial peptide of the brevinin-1
family in the skin of a Ranid frog in response to environ-
mental change. The data provide support for the proposal
that such peptides are important in protecting the animal
against microbial invasion.
2. Materials and methods
2.1. Animals
Adult male specimens of wood frog R. sylvatica (weight range 3.9^
5.1 g) were collected during the time of the spring thaw from breeding
ponds in the Ottawa region. The temperature of the water was always
6 7‡C. The animals were transported to the laboratory and housed in
plastic boxes containing wet moss at 5‡C. Skin (21 g) was taken from
these cold-acclimated specimens (n = 40) and immediately frozen in
liquid nitrogen. Other specimens (n = 23) were shipped to Creighton
University on ice and were acclimated gradually over a period of 48 h
to a temperature of 30 þ 2‡C. The animals were housed at this temper-
ature and after 1 week began feeding. A meal of crickets was given
every 3 days. After 3 weeks, the animals were sacri¢ced by pithing and
skin (12 g) was removed and immediately frozen on dry-ice.
2.2. Tissue extraction
The frozen skins from 5 and 30‡C-acclimated frogs were separately
extracted by homogenization in ethanol/0.7 M HCl (3:1 v/v; 10 ml
g31) at 0‡C using a Waring blender. The homogenates were stirred for
2 h at 0‡C and centrifuged (4000Ug for 30 min at 4‡C). Ethanol was
removed from the supernatants under reduced pressure and, after
further centrifugation (4000Ug for 30 min at 4‡C), the extracts
were separately pumped onto 4 Sep-Pak C-18 cartridges (Waters
Associates, Milford, MA, USA) connected in series at a £ow rate of
2 ml/min. Bound material was eluted with acetonitrile/water/tri£uoro-
acetic acid (70.0:29.9:0.1, v/v/v) and freeze-dried.
2.3. Antimicrobial assays
Minimal inhibitory concentrations (MICs) of the peptides were de-
termined by a standard microdilution method using 96-well microtiter
cell-culture plates as previously described [10]. Serial dilutions of the
peptides in Mueller^Hinton broth (50 Wl) were incubated with an
inoculum (50 Wl of 103 cfu/ml) from an overnight culture of Escheri-
chia coli (ATCC 25922) and Staphylococcus aureus (NCTC 8325), for
18 h at 37‡C in a humidi¢ed atmosphere of 5% CO2 in air. After
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incubation, the absorbance at 550 nm of each well was determined
using an M.A. Bioproducts model MA308 microtiter plate reader.
The MIC of each peptide was taken as the lowest concentration where
no visible growth was observed. In order to monitor the validity of
the assay, incubations with E. coli and S. aureus were carried out in
parallel with increasing concentrations of the broad-spectrum antibi-
otic, bacitracin.
2.4. Peptide puri¢cation
Each skin extract, after partial puri¢cation on Sep-Pak cartridges,
was redissolved in 1% (v/v) tri£uoroacetic acid/water (5 ml) and in-
jected onto a (25U1 cm) Vydac 218TP510 C-18 reverse-phase high
performance liquid chromatography (HPLC) column (Separations
Group, Hesperia, CA, USA) equilibrated with 0.1% (v/v) tri£uoro-
acetic acid/water at a £ow rate of 2 ml min31. The concentration of
acetonitrile in the eluting solvent was raised to 21% (v/v) over 10 min
and to 49% (v/v) over 60 min using linear gradients. Absorbance was
monitored at 214 and 280 nm and fractions (1 min) were collected.
The ability of aliquots (50 Wl) of the fractions to inhibit the growth of
S. aureus and E. coli was determined as described in Section 2.3.
Fractions containing maximum activity (denoted by the bar in
Fig. 1) were pooled and were successively rechromatographed on
(25U1 cm) Vydac 214TP510 (C-4) and Vydac 219TP510 (phenyl)
reverse-phase HPLC columns. In both cases, the concentration of
acetonitrile in the eluting solvent was raised from 35 to 65% over
40 min.
2.5. Structural analysis
Hydrolysis in 5.7 M HCl (24 h at 110‡C) of approximately 1 nmol
of peptide was carried out. Amino acid compositions were determined
by precolumn derivatization with 6-aminoquinolyl-N-hydroxysuccini-
midyl carbamate using a Waters AccQ Tag system with £uorescence
detection and separation of the amino acid derivatives by reverse-
phase HPLC. The primary structures of the peptides were determined
by automated Edman degradation using an Applied Biosystems mod-
el 491 sequenator. Electrospray mass spectrometry was carried out
using a Perkin Elmer Sciex API 150EX single quadrupole instrument.
The accuracy of mass determinations was þ 0.02%.
3. Results
3.1. Peptide puri¢cation
The elution pro¢le on a semi-preparative Vydac C-18 re-
verse-phase HPLC column of the extract of R. sylvatica skin
from 30‡C-acclimated animals, after partial puri¢cation on
Sep-Pak cartridges, is shown in Fig. 1A. Growth-inhibiting
activity against both S. aureus and E. coli was eluted from
the column in a single broad fraction, denoted by the bar.
Further puri¢cation on Vydac C-4 (Fig. 2A) and Vydac phe-
nyl (Fig. 2B) columns demonstrated that the antimicrobial
activity was associated with a single component, subsequently
identi¢ed as brevinin-1SY, that was puri¢ed to near homoge-
neity. The ¢nal yield of pure peptide was 48 nmol. In contrast,
no fraction from chromatography of the skin extract from
5‡C-acclimated frogs on the Vydac C-18 column (Fig. 1B)
inhibited the growth of either S. aureus or E. coli when tested
under the same assay conditions using up to 200 Wl aliquots of
each fraction.
3.2. Peptide characterization
The primary structure of the antimicrobial peptide (brevi-
nin-1SY) was established by automated Edman degradation
and is shown in Fig. 3. The amino acid composition of the
peptide in residues/mol peptide was determined as: [Ser 1.0
(1), Gly 1.1 (1), Thr 1.0 (1), Ala 3.7 (4), Pro 2.0 (2), Val 3.4
(4), Lys 2.8 (3). Ile 1.4 (2), Leu 2.8 (3), Phe 1.0 (1)] which was
consistent with the sequence analysis data and demonstrated
that the full sequence had been obtained. The values in pa-
rentheses are the number of residues predicted from the pro-
posed structure. The presence of a cystine bridge in the pep-
tide was shown by mass spectrometry (Mr observed 2440.2;
Mr calculated for the reduced peptide 2440.1).
The MIC of brevinin-1SY was 7 WM against the Gram-
positive bacterium S. aureus and 45 WM against the Gram-
negative bacterium E. coli.
4. Discussion
The present study, by demonstrating that synthesis of an
antimicrobial peptide in frog skin is induced in response to
environmental in£uences, has provided evidence to support
the hypothesis that such peptides play a physiologically im-
portant role in defending the organism against invasion by
microorganisms. Fasting animals, collected immediately after
hibernation in the frozen state and maintained at 5‡C did not
have detectable concentrations of antimicrobial components
in the skin. Under these circumstances, the bacterial challenge
to the animal was weak. In contrast, animals maintained at
Fig. 1. Reverse-phase HPLC on a semipreparative Vydac C-18 column of an extract of R. sylvatica skin from animals maintained at (A) 30‡C
and (B) 5‡C. The bar designates those fractions with growth-inhibitory activity towards S. aureus. The dashed line shows the concentration of
acetonitrile in the eluting solvent.
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30‡C that were feeding and defecating vigorously synthesized
relatively high concentrations of an antimicrobial peptide of
the brevinin-1 family that was active against both Gram-neg-
ative (E. coli) and Gram-positive (S. aureus) bacteria. These
circumstances mimic the conditions in the wild in late spring
and are conducive to the growth of bacteria. Adopting the
terminology of Simmaco et al. [13], the antimicrobial peptide
is described as brevinin-1SY to indicate its species of origin (S
has already been used for Rana sphenocephala [14]). The reg-
ulation of the synthesis of antimicrobial peptides in frog skin
has not been studied extensively but a previous study has
shown that treatment of the frog Rana esculenta with gluco-
corticoids inhibits synthesis of antimicrobial peptides by a
mechanism that involves up-regulation of the inhibitor of
transcription IUBK [15].
Peptides of the brevinin-1 family were ¢rst isolated from the
skin of the Asian frog, Rana brevipoda porsa [16] and subse-
quently from a wide range of European (R. esculenta), Asian
(Rana rugosa) and North American (Rana catesbeiana, Rana
luteiventris, Rana berlandieri, Rana pipiens, R. sphenocephala,
Rana palustris) species (reviewed in [9,10,17]). All members of
the family characterized to date comprise 24 amino acid res-
idues and contain a C-terminal cystine-bridged, heptapeptide
ring. The primary structures of selected brevinin-1 peptides
are shown in Fig. 3 in order to demonstrate that conservation
of amino acid sequence in the family has been very poor. Only
four residues (Pro3, Ala9, Cys18, Lys23, Cys24) are invariant in
the known peptides. However, all brevinin-1 peptides contain
a preponderance of basic residues (primarily lysine) and have
the ability to adopt amphipathic K-helical conformations
upon interaction with the lipid bilayer of the bacterial cell
membrane [18]. The family belongs, therefore, to a wider
group of cationic peptide antibiotics whose common mecha-
nism of action has been discussed [19].
An unexpected feature of the study was the observation
that the skin of R. sylvatica produced only a single detectable
antimicrobial peptide. In general, a particular amphibian spe-
cies synthesizes a range of antimicrobial peptides belonging to
di¡erent families with each family containing several isoforms.
For example, 22 antimicrobial peptides belonging to eight
di¡erent families have been isolated from skin secretion of
the pickerel frog, R. palustris [17]. Despite the sequence sim-
ilarities, the members of a particular family have a distinct
spectra of antimicrobial activity and it has been speculated
that this molecular diversity is important in protecting the
animal from invasion by a wide array of di¡erent microorgan-
isms [20]. In view of the pronounced decline in frog popula-
tions throughout North America, studies are clearly war-
ranted to assess the ability of brevinin-1SY to inhibit the
growth of those pathogenic microorganisms that the wood
frog may encounter in the wild.
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